Davis Investment Partners »

BioMarin Pharmaceutical shares owned by Davis Investment Partners

Quarter-by-quarter ownership of BioMarin Pharmaceutical (BMRN) shares owned by Davis Investment Partners from 13F filings

Historical chart of Davis Investment Partners investment in BioMarin Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including BioMarin Pharmaceutical held by Davis Investment Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in BioMarin Pharmaceutical by Davis Investment Partners

Quarter filed Position value Share count Share price at filing
2025-09-30 $427k 7.8k 54.86
2025-06-30 $438k 7.8k 56.19
2025-03-31 $533k 8.9k 59.67

More positions owned by Davis Investment Partners

Invesco Exchange Traded Fd T S&p500 Eql Tec (RSPT)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Invesco Exchange Traded Fd T S&p500 Eql Ind (RSPN)
Vanguard Index Fds Mcap Gr Idxvip (VOT)
Amphenol Corp Cl A (APH)
Janus Detroit Str Tr Hendrson Aaa Cl (JAAA)
Apple (AAPL)
First Tr Exchange-traded SHS (QQEW)
Microsoft Corporation (MSFT)
Invesco Exchange Traded Fd T S&p500 Eql Fin (RSPF)
Vanguard World Inf Tech Etf (VGT)
Johnson & Johnson (JNJ)
Exxon Mobil Corporation (XOM)
Bank of America Corporation (BAC)
First Tr Exchange Traded Risng Divd Achiv (RDVY)

View all positions for Davis Investment Partners

Top funds holding BioMarin Pharmaceutical

BlackRock
Vanguard Group
PRIMECAP Management Company
Dodge & Cox
State Street Corporation
Viking Global Investors
AQR Capital Management
Geode Capital Management
Millennium Management
Capital Research Global Investors
Morgan Stanley
Goldman Sachs Group
Dimensional Fund Advisors
Renaissance Technologies
Northern Trust

View all funds holding BioMarin Pharmaceutical